Fireside Chat: Sen. Shelley Moore Capito

Session Focus

The conversation covered federal research funding, the mechanics of getting health legislation through a divided Senate, the indirect cost debate, and Capito’s own legislative priorities. As chair of the appropriations subcommittee covering Labor, Health and Human Services, and Education, she spoke from direct budgetary responsibility for NIH.

How Bipartisan Work Still Happens

Capito described the Senate’s 60-vote threshold as the structural reason compromise remains necessary, regardless of how polarized the broader environment becomes. Legislation cannot move without members from both parties.

She pointed to the most recent NIH appropriation as the concrete result. The Senate increased NIH funding by $415 million, a number arrived at through negotiation rather than party-line action.

Certainty as the Core Need

Asked what the research community most needs from Washington, Capito did not name a funding level. She named predictability.

Her reasoning was operational. Universities and research institutions plan laboratory space, hiring and multi-year projects against expected funding. When that expectation becomes unreliable, planning and budgeting break down regardless of the eventual appropriation.

Her greatest concern was the human consequence: institutions reducing or eliminating postdoctoral positions, other countries actively recruiting American scientists, and early-career researchers leaving the pipeline entirely.

Her framing was long-range. Losing young scientists now determines where the American research enterprise stands in fifteen years, and that damage is not quickly reversed.

The Indirect Cost Debate

Capito was candid about her own learning curve on facilities and administrative costs, describing it as a subject she had to work to understand.

Her frustration was with transparency. She asked several leading universities to walk her through how indirect cost recovery was actually spent on a single grant, and found that no one had proactively provided that explanation before she requested it.

She explained why the FAIR model was ultimately set aside in favor of maintaining the current approach for the time being.

Her conclusion was directed at the institutions in the room: the substantive case for the current model is sound, but it is being made poorly. Members of Congress and their staff need that education, and research institutions are the ones positioned to deliver it.

Legislative Priorities

Alzheimer’s disease. Capito spoke about this personally, noting that both of her parents had the disease. She has introduced legislation to expand Medicare coverage for blood-based biomarker testing, reflecting how earlier diagnosis is becoming clinically actionable.

Pediatric cancer research. A continuing area of focus in her appropriations work.

340B reform. Named as an area requiring legislative attention.

Rural health and telehealth. She identified telehealth funding as a strong candidate for permanent authorization rather than the repeated short-term extensions it has received.

Key Takeaways

1. Predictability matters as much as funding levels. Uncertainty damages the research enterprise independently of the eventual appropriation.

2. The pipeline is the vulnerable point. Postdoctoral positions and early-career researchers are where disruption shows up first and takes longest to repair.

3. The indirect cost case needs better advocacy. Institutions should proactively explain how the money is used rather than waiting to be asked.

4. Bipartisan mechanics still function. The 60-vote threshold forces negotiation, and the NIH increase demonstrates it.

5. Personal experience shapes priorities. Her Alzheimer’s legislation traces directly to her parents’ diagnoses.